Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis

JAMA - Journal of the American Medical Association

Volumn 315, Issue 14, 2016, Pages 1469-1479

  Van Vught, Lonneke A V ^a   Klouwenberg, Peter M C Klein ^b   Spitoni, Cristian ^c   Scicluna, Brendon P ^a   Wiewel, Maryse A ^a   Horn, Janneke ^a   Schultz, Marcus J ^a   Nürnberg, Peter ^d   Bonten, Marc J M ^b   Cremer, Olaf L ^b   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ADULT; AGE DISTRIBUTION; AGED; APACHE; ARTICLE; ATTRIBUTABLE RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY ASSESSMENT; FEMALE; GENE EXPRESSION; GLUCONEOGENESIS; GLYCOLYSIS; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NETHERLANDS; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SECONDARY INFECTION; SEPSIS; SEX RATIO; CATHETER-RELATED INFECTIONS; COMPLICATION; CROSS INFECTION; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HOSPITAL MORTALITY; IMMUNOLOGY; LENGTH OF STAY; ORGAN DYSFUNCTION SCORE; SEPTIC SHOCK; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

AGED; APACHE; CATHETER-RELATED INFECTIONS; CROSS INFECTION; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NETHERLANDS; ORGAN DYSFUNCTION SCORES; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVAL ANALYSIS;

EID: 84963795607     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.2691     Document Type: Article

References (34)

1. Vincent JL, Marshall JC, Namendys-Silva SA, et al; ICON Investigators. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014;2(5):380-386.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-1310.
3. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594-2605.
4. Leentjens J, Kox M, Van Der Hoeven JG, Netea MG, Pickkers P. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation; time for a paradigm change? Am J Respir Crit Care Med. 2013;187(12):1287-1293.
5. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862-874.
6. Hutchins NA, Unsinger J, Hotchkiss RS, Ayala A. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014;20(4):224-233.
7. Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20(4):195-203.
8. ∗. Crit Care Med. 2014;42(7):1714-1721.
9. Klein Klouwenberg PM, Ong DS, Bos LD, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med. 2013;41(10):2373-2378.
10. Klein Klouwenberg PM, Van Mourik MS, Ong DS, et al; MARS Consortium. Electronic implementation of a novel surveillance paradigm for ventilator-associated events: feasibility and validation. Am J Respir Crit Care Med. 2014;189(8):947-955.
11. Oostdijk EA, Kesecioglu J, Schultz MJ, et al. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA. 2014;312(14):1429-1437.
12. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-140.
13. Calandra T, Cohen J; International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33(7):1538-1548.
14. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-1256.
15. Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med. 2006;34(5):1297-1310.
16. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311(13):1308-1316.
17. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S, eds. Bioinformatics and Computational Biology Solutions Using R. New York, NY: Springer; 2005:397-420.
18. Van Lieshout MH, Scicluna BP, Florquin S, Van Der Poll T. NLRP3 and ASC differentially affect the lung transcriptome during pneumococcal pneumonia. Am J Respir Cell Mol Biol. 2014;50(4):699-712.
19. Scicluna BP, Klein Klouwenberg PM, Van Vught LA, et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am J Respir Crit Care Med. 2015;192(7):826-835.
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, B. 1995;57(1):289-300.
21. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. http://www.r-project.org. Published 2013. Accessed March 7, 2016.
22. Wolkewitz M, Cooper BS, Palomar-Martinez M, et al. Multilevel competing risk models to evaluate the risk of nosocomial infection. Crit Care. 2014;18(2):R64.
23. Coeurjolly JF, Nguile-Makao M, Timsit JF, Liquet B. Attributable risk estimation for adjusted disability multistate models: application to nosocomial infections. Biom J. 2012;54(5):600-616.
24. Schumacher M, Wangler M, Wolkewitz M, Beyersmann J. Attributable mortality due to nosocomial infections: a simple and useful application of multistate models. Methods Inf Med. 2007;46(5):595-600.
25. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389-2430.
26. Vincent JL, Bihari DJ, Suter PM, et al; EPIC International Advisory Committee. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA. 1995;274(8):639-644.
27. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol. 2000;21(8):510-515.
28. Wong HR. Clinical review: sepsis and septic shock-the potential of gene arrays. Crit Care. 2012;16(1):204.
29. O'Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493(7432):346-355.
30. Palsson-McDermott EM, O'Neill LA. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays. 2013;35(11):965-973.
31. Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, et al. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 2014;76(1):21-29.
32. Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40(4):463-475.
33. De Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360(1):20-31.
34. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.